The Indian IP Office has scheduled the Patent and Trademark Agent Examinations for January 2025. This announcement details eligibility, exam format, and inclusivity measures, inviting aspiring professionals including persons with disabilities to apply.
Read more about Announcement: Patent and Trademark Agent Examinations 2025 by Indian IP OfficeCategory: Intellectual Property
Marc Salon’s Design Makes the Cut: Court Grants Injunction
The Delhi High Court has upheld an injunction protecting Marc Salon’s salon furniture designs against GM Sales, recognising their originality and market reputation. The Court found strong evidence of passing off and copyright infringement, confirming Marc Salon’s entitlement to legal protection.
Read more about Marc Salon’s Design Makes the Cut: Court Grants Injunction‘Controller under an obligation to inform inventor’ says Madras High Court
The Madras High Court stressed that patent Controllers are obliged to provide detailed reasoning for refusals, enabling inventors to understand the grounds for rejection. The Court set aside two refusal orders and ordered fresh consideration, reinforcing the importance of transparency and due process in Indian patent law.
Read more about ‘Controller under an obligation to inform inventor’ says Madras High CourtWe cannot stop Yakshini, says the Delhi High Court
The Delhi High Court rejected Pocket FM’s application for an interim injunction against the release of Novi Digital’s Yakshini series. The court found no prima facie copyright infringement and allowed the series to proceed.
Read more about We cannot stop Yakshini, says the Delhi High CourtMRF’s Trademark Muscle Secures Victory in Dispute Against Powermax
The Madras High Court granted MRF a permanent injunction and nominal damages against Powermax for trademark and copyright infringement. The judgment underscores the legal significance of safeguarding established trademarks in India.
Read more about MRF’s Trademark Muscle Secures Victory in Dispute Against PowermaxCourt Lifts injunction on Tractor-Forklift Design
The Madras High Court lifted an injunction on a tractor-forklift design, finding the design not new or original under Indian law. The case highlights the requirements for design registration and addresses the boundaries of industrial design protection.
Read more about Court Lifts injunction on Tractor-Forklift DesignAnother Dis’connected’ order by the registry, set aside by the Court
The Calcutta High Court set aside a trademark refusal for Electronica India due to lack of reasoning and significant procedural lapses, instructing the registry to provide a fresh hearing. The order highlights the importance of fair hearing practices in Indian trademark law.
Read more about Another Dis’connected’ order by the registry, set aside by the CourtKarnataka High Court to form IP Division: Sub-Committee notified
The Karnataka High Court has announced steps to establish an IP Division by forming a dedicated sub-committee to draft relevant rules. This notification brings Karnataka in line with other major High Courts in India, though no timeline for rule submission has been provided.
Read more about Karnataka High Court to form IP Division: Sub-Committee notifiedDelhi High Court Reverses Patent Office Decision: Honeywell’s Amendments Upheld
The Delhi High Court overturned the Patent Office’s refusal of Honeywell’s patent amendments, holding that the changes were within the scope of the original claims. This ruling affirms the importance of fair and thorough examination of patent applications under Indian law.
Read more about Delhi High Court Reverses Patent Office Decision: Honeywell’s Amendments UpheldDiabetic Product XigaMet Loses to ZitaMet Under Heightened Pharma Trademark Scrutiny
The Bombay High Court has restrained Gleck Pharma from using XIGAMET for its diabetes product, finding it deceptively similar to Glenmark’s ZITA-MET. This decision highlights the Court’s heightened scrutiny in pharmaceutical trademark cases to prevent consumer confusion and associated health risks.
Read more about Diabetic Product XigaMet Loses to ZitaMet Under Heightened Pharma Trademark Scrutiny